Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria [0.03%]
杜普利尤单抗可减轻不同临床类型皮肤病的瘙痒：特应性皮炎、结节性痒疹和慢性自发性荨麻疹临床试验数据的分析纠正意见
Gil Yosipovitch,Brian S Kim,John Y Koo et al.
Gil Yosipovitch et al.
Published Erratum
Dermatology and therapy. 2026 Mar 18. DOI:10.1007/s13555-026-01671-8 2026
Comparison of the Effects and Safety of Planned Limited-Time Withdrawal Versus Continuous Maintenance of Interleukin Inhibitors in Patients with Psoriasis: A Systematic Review and Network Meta-Analysis [0.03%]
计划性间歇用药与持续维持生物制剂治疗银屑病疗效和安全性的比较：系统评价和网络 meta 分析
Rodrigo R de Sena,Kleyton de C Mesquita,Letícia F Barroso et al.
Rodrigo R de Sena et al.
Introduction: Recent trials with withdrawal arms in patients with psoriasis have highlighted the need for updated clinical guidance. The aim of this investigation was to compare the effects and safety of planned limited-t...
A Narrative Review of Local Therapies in Hidradenitis Suppurativa: Treatment Landscape and Current Issues [0.03%]
汗腺炎局部治疗的叙事性回顾：治疗现状与当前问题
Elisa Molinelli,Davide Febi,Edoardo De Simoni et al.
Elisa Molinelli et al.
Hidradenitis suppurativa (HS) is an insidious, chronic inflammatory skin disease, leading to a negative impact on a patient's quality of life and a poor prognosis. The pathogenesis of HS is complex and multifaceted including genetic, sex ho...
Comorbidities in Discoid Lupus: A Systematic Review and Meta-analysis of Prevalence and Association [0.03%]
盘状红斑狼疮合并症的系统性回顾和荟萃分析：患病率及关联性
Juan Luis Sanz-Cabanillas,Francisco José Gómez-García,Elena Beatriz Sanz-Cabanillas et al.
Juan Luis Sanz-Cabanillas et al.
Introduction: Discoid lupus erythematosus (DLE) is a chronic inflammatory scarring alopecia that may be accompanied by a broad range of systemic and extracutaneous comorbidities. However, the prevalence and magnitude of t...
Impact of Chronic Nodular Prurigo on Quality of Life: A Systematic Review of the Literature [0.03%]
慢性结节性痒疹对生活质量的影响：文献系统综述
Pedro Herranz Pinto,Bibiana Pérez García,Victoria Bonne Moreno et al.
Pedro Herranz Pinto et al.
Introduction: Chronic nodular prurigo (CNPG), also known as prurigo nodularis, is an inflammatory neuroimmune skin disorder characterized by intense pruritus and nodular lesions resulting from scratching. CNPG affects pat...
Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis) [0.03%]
德鲁伐单抗治疗银屑病短期疗效和安全性：一项多中心真实世界研究（意大利银屑病分布研究）-头皮特异性结局
Luciano Ibba,Sara Di Giulio,Piergiorgio Malagoli et al.
Luciano Ibba et al.
Introduction: Real-world evidence on deucravacitinib in moderate-to-severe psoriasis remains limited, especially regarding difficult-to-treat areas such as scalp involvement. We conducted a multicenter retrospective study...
Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis with Diabetes: Pooled Subgroup Analysis of reSURFACE 1 and reSURFACE 2 [0.03%]
Tilakizumab治疗中至重度斑块型银屑病伴糖尿病的有效性和安全性：reSURFACE 1和reSURFACE 2研究亚组分析的汇总结果
Jerry Bagel,Ranga Gogineni,Asif Shaikh et al.
Jerry Bagel et al.
Introduction: Psoriasis may increase risk for comorbid diabetes and obesity. Tildrakizumab, an anti-interleukin-23 monoclonal antibody approved for the treatment of adults with moderate-to-severe plaque psoriasis, was eva...
AVT04, a Biosimilar to Reference Product Ustekinumab, for the Treatment of Plaque Psoriasis: Insights from a Real-World Experience up to 28 Weeks [0.03%]
一种依那西普参考药物的生物仿制药(AVT04)治疗斑块状银屑病的真实世界研究经验（长达28周）
Edoardo Mortato,Marina Talamonti,Lorenzo Savastano et al.
Edoardo Mortato et al.
Introduction: This study aims to evaluate the real-life efficacy and safety of a biosimilar to reference product (RP) ustekinumab for the treatment of plaque psoriasis in different patient scenarios. The cohort included u...
Holistic Value Assessment of Tirbanibulin for Actinic Keratosis: European Multi-Criteria Decision Analysis [0.03%]
替拉班布林治疗角化病的综合价值评估：欧洲多标准决策分析
Carola Berking,Rafael Botella,Andrea Carugno et al.
Carola Berking et al.
Introduction: Actinic keratosis (AK) is a prevalent, chronic skin condition and a precursor to cutaneous squamous cell carcinoma. Effective, patient-friendly therapies that target both visible and subclinical lesions are ...
Jorge Sánchez
Jorge Sánchez
Patients with chronic illnesses, especially those with autoimmune conditions such as rheumatoid arthritis, chronic urticaria, Crohn's disease, psoriasis, and diabetes, rely on injectable therapies for disease management. However, it is well...